Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Most readers would already be aware that Stryker's (NYSE:SYK) stock increased significantly by 11% over the past ...

Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment ...

Stryker Corporation's innovation and market leadership justify a premium. See why SYK stock is a solid hold with long-term ...

Here are eight things for ASCs to know about the sale: 1. Stryker's U.S. spine segment will be sold to investment firm Viscogliosi Brothers. 2. That group will create VB Spine, which will be a ...

In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Stryker (SYK – Research Report), with a price target of ...

Stryker SYK has outperformed the market over ... The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of ...